Fmr LLC grew its position in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Rating) by 96.1% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,742,968 shares of the biotechnology company’s stock after acquiring an additional 1,344,444 shares during the period. Fmr LLC’s holdings […]
Arrowhead Pharmaceuticals, Inc (NASDAQ:ARWR) Receives Consensus Recommendation of Buy from Brokerages etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.